The DNA sequencing market in China is expected to reach 18.3B Yuan by 2022, rising from 7.2B Yuan last year at a much greater rate than the overall global market.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
The NIH has committed up to $45.5M to support its Somatic Cell Genome Editing programme. The money will make up a series of grants to be paid over the next four fiscal years.
US representatives are pressing genetic testing companies for details on their security systems and customer privacy policies.
Billionaire philanthropist Bill Gates has donated $30 million towards incentivising the development of an Alzheimer’s diagnostic test.
Verge Genomics, the drug discovery startup we recently featured in our Top 5 Startups Disrupting Healthcare, has raised $32 million in Series A financing.
Even in light of the rising fears of “superbugs” in the world of big pharma, the marginal profits made through the development of antibiotics isn’t enough to justify the research.
Founded in 1790, the Patent Office aimed to put innovation and entrepreneurship within reach of every citizen. Now, 10 million patents later, critics say an out-of-touch system is doing the opposite.
Chinese investors have poured more money into the US biotech market in the first six months of 2018 than they did in the entirety of last year.
Francisco Ayala, a renowned evolutionary biologist at the University of California, Irvine, has resigned his position after an investigation into sexual harassment allegations against him.